Junghoon Shin Jeong-Ok Lee Ji-Young Choe Soo-Mee Bang Jong-Seok Lee
10.4143/crt.2016.076
Cancer Res Treat
2017 Jan;49(1):274-278.
human herpesvirus 8 primary effusion lymphoma r-chop protocol
CC BY-NC
https://pubmed.ncbi.nlm.nih.gov/27283030/
Antineoplastic Combined Chemotherapy Protocols / therapeutic use Herpesviridae Infections / complications Herpesvirus 8, Human Lymphoma, Primary Effusion / drug therapy Lymphoma, Primary Effusion / etiology
Antineoplastic Combined Chemotherapy Protocols / therapeutic use Herpesviridae Infections / complications Herpesvirus 8, Human Lymphoma, Primary Effusion / drug therapy Lymphoma, Primary Effusion / etiology Case Reports Age Factors Aged Antibodies, Monoclonal, Murine-Derived / adverse effects Antibodies, Monoclonal, Murine-Derived / therapeutic use Antineoplastic Combined Chemotherapy Protocols / adverse effects Biomarkers Biopsy Cyclophosphamide / adverse effects Cyclophosphamide / therapeutic use Doxorubicin / adverse effects Doxorubicin / therapeutic use Humans Lymphoma, Primary Effusion / diagnosis Male Multimodal Imaging / methods Prednisone / adverse effects Prednisone / therapeutic use Remission Induction Rituximab Treatment Outcome Vincristine / adverse effects Vincristine / therapeutic use Antibodies, Monoclonal, Murine-Derived Biomarkers R-CHOP protocol Rituximab Vincristine Doxorubicin Cyclophosphamide Prednisone
PMC5266403
27283030
Human Herpesvirus 8-Unrelated Primary Effusion Lymphoma-Like Lymphoma in an Elderly Korean Patient with a Good Response to Rituximab Plus Cyclophosphamide, Doxorubicin, Vincristine, and Prednisolone
2017